The accuracy of MRI, endorectal ultrasonography, and computed tomography in predicting the response of locally advanced rectal cancer after preoperative therapy: A metaanalysis
- PMID:26619929
- DOI: 10.1016/j.surg.2015.10.019
The accuracy of MRI, endorectal ultrasonography, and computed tomography in predicting the response of locally advanced rectal cancer after preoperative therapy: A metaanalysis
Abstract
Background: To perform a metaanalysis to determine and compare the diagnostic performance of MRI, endorectal ultrasonography (ERUS), and computed tomography (CT) in predicting the response of locally advanced rectal cancer after preoperative therapy.
Methods: All previously published articles on the role of MRI, CT, and/or ERUS in predicting the response of rectal cancer to preoperative therapy were collected. We divided the objective in 3 parts: the accuracy to assess (i) complete response, (ii) to detect T4 tumors with invasion to the circumferential resection margin (CRM), and (iii) to predict the presence of lymph node metastasis. The pooled estimates of, sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were calculated using a bivariate mixed effect analysis.
Results: Forty-six studies comprising 2,224 patients were included. (i) The pooled accuracy to assess complete tumor response were (a) 75% for MRI, (b) 82% for ERUS, (c) and 83% for CT. (ii) Pooled accuracy to detect T4 tumors with invasion to the CRM were (a) 88% and (b) 94% for ERUS. (iii) Pooled accuracy to predict the presence of lymph node metastasis was (a) 72% for MRI, (b) 72% for ERUS, (c) and 65% for CT.
Conclusion: MRI, CT, and ERUS cannot be used to predict complete response of locally advanced rectal cancer after CRT. In addition, the positive predictive value for these imaging techniques is low for the assessment of tumor invasion in the CRM. The accuracy of the modalities to predict the presence of metastatic lymph node disease is also low.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
- Can Endorectal Ultrasound, MRI, and Mucosa Integrity Accurately Predict the Complete Response for Mid-Low Rectal Cancer After Preoperative Chemoradiation? A Prospective Observational Study from a Single Medical Center.Liu S, Zhong GX, Zhou WX, Xue HD, Pan WD, Xu L, Lu JY, Wu B, Lin GL, Qiu HZ, Xiao Y.Liu S, et al.Dis Colon Rectum. 2018 Aug;61(8):903-910. doi: 10.1097/DCR.0000000000001135.Dis Colon Rectum. 2018.PMID:29944579
- Correlation Between Endorectal Ultrasound and Magnetic Resonance Imaging for Predicting the Circumferential Resection Margin in Patients With Mid-Low Rectal Cancer Without Preoperative Chemoradiotherapy.Ye D, Zhu Z, Chen F, Lie C, Li W, Lin Y, Qiu S.Ye D, et al.J Ultrasound Med. 2020 Mar;39(3):569-577. doi: 10.1002/jum.15135. Epub 2019 Oct 16.J Ultrasound Med. 2020.PMID:31617244
- Accuracy of endorectal ultrasonography and computed tomography for restaging rectal cancer after preoperative chemoradiation.Huh JW, Park YA, Jung EJ, Lee KY, Sohn SK.Huh JW, et al.J Am Coll Surg. 2008 Jul;207(1):7-12. doi: 10.1016/j.jamcollsurg.2008.01.002. Epub 2008 Apr 14.J Am Coll Surg. 2008.PMID:18589355
- Anorectal staging: is EUS necessary?Cesmeli E.Cesmeli E.Minerva Med. 2014 Oct;105(5):423-36. Epub 2014 Jul 7.Minerva Med. 2014.PMID:25000219Review.
- Imaging in rectal cancer: magnetic resonance imaging versus endorectal ultrasonography.Samdani T, Garcia-Aguilar J.Samdani T, et al.Surg Oncol Clin N Am. 2014 Jan;23(1):59-77. doi: 10.1016/j.soc.2013.09.011.Surg Oncol Clin N Am. 2014.PMID:24267166Review.
Cited by
- Diagnostic accuracy of endoscopic ultrasound, computed tomography, magnetic resonance imaging, and endorectal ultrasonography for detecting lymph node involvement in patients with rectal cancer: A protocol for an overview of systematic reviews.Wang X, Gao Y, Li J, Wu J, Wang B, Ma X, Tian J, Shen M, Wang J.Wang X, et al.Medicine (Baltimore). 2018 Oct;97(43):e12899. doi: 10.1097/MD.0000000000012899.Medicine (Baltimore). 2018.PMID:30412090Free PMC article.
- Sense and non-sense of imaging in the era of organ preservation for rectal cancer.Ou X, van der Reijd DJ, Lambregts DM, Grotenhuis BA, van Triest B, Beets GL, Beets-Tan RG, Maas M.Ou X, et al.Br J Radiol. 2023 Nov;96(1151):20230318. doi: 10.1259/bjr.20230318. Epub 2023 Sep 26.Br J Radiol. 2023.PMID:37750870Free PMC article.Review.
- Can rectal MRI and endorectal ultrasound accurately predict the complete response to neoadjuvant immunotherapy for rectal cancer?Zhai M, Lin Z, Wang H, Yang J, Li M, Li X, Zhang L, Zhang T.Zhai M, et al.Gastroenterol Rep (Oxf). 2024 Apr 8;12:goae027. doi: 10.1093/gastro/goae027. eCollection 2024.Gastroenterol Rep (Oxf). 2024.PMID:38590912Free PMC article.
- Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Gurski L, Freedman-Cass DA.Benson AB, et al.J Natl Compr Canc Netw. 2018 Jul;16(7):874-901. doi: 10.6004/jnccn.2018.0061.J Natl Compr Canc Netw. 2018.PMID:30006429Free PMC article.
- MRI VS. FDG-PET for diagnosis of response to neoadjuvant therapy in patients with locally advanced rectal cancer.Gao PF, Lu N, Liu W.Gao PF, et al.Front Oncol. 2023 Jan 18;13:1031581. doi: 10.3389/fonc.2023.1031581. eCollection 2023.Front Oncol. 2023.PMID:36741013Free PMC article.Review.
Publication types
MeSH terms
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials